Compare Weight Loss Injections UK

In clinical trials, tirzepatide (Mounjaro) has produced a larger average weight loss than semaglutide (Wegovy). Average trial results are not a prediction for any individual, though. Which treatment is most effective for you depends on your medical history, how well you tolerate the medicine, whether you can commit to weekly or daily injections, and what you can sustain financially. That decision is made with a prescriber, not from a table.

Some are, but access is restricted and the criteria are strict. NHS prescribing generally depends on your BMI, whether you have weight-related health conditions, and referral through a weight management service, and availability differs across England, Scotland, Wales and Northern Ireland. Waiting times can be long, which is why many people look at private prescription services instead. Your GP is the right starting point for checking whether you qualify.

Yes. Both are licensed as an addition to a reduced-calorie diet and increased physical activity, not as a replacement for them. The trial results these medicines are measured against were achieved alongside those changes. Diet and activity also protect muscle mass while you lose weight, and give you something to hold on to if you come off treatment later.